{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:24:58Z","timestamp":1780637098622,"version":"3.54.1"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Stimulator of interferon response cGAMP interactor (STING) is essential for both innate and adaptive immunity. However, a comprehensive molecular characterization of STING expression across hematological malignancies is lacking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, the pan-blood-cancer landscape related to STING expression was identified using the GTEx, CCLE, Hemap, and TCGA databases, and the potential value for predicting prognosis was investigated. The relationship between STING expression and immune cell enrichment was assessed in the Hemap database. Moreover, the value of STING in predicting the efficacy of immunotherapy was validated using tumor immune dysfunction and exclusion (TIDE) biomarkers and real-world immunotherapy datasets.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results and Discussion<\/jats:title><jats:p>STING was found to be relatively highly expressed in acute myeloid leukemia (AML) and chronic myeloid leukemia, with higher STING expression correlated with poorer prognosis in AML. STING expression was positively correlated with immune-related pathways such as IFN-gamma response, IFN-alpha response, and inflammatory response. Cytolytic score and STING expression were positively correlated in some hematological tumors, especially chronic lymphocytic leukemia and mantle cell lymphoma. Interestingly, STING expression was negatively correlated with TIDE biomarkers in AML, suggesting that AML patients with a high STING expression level may benefit from immunologic treatment. Our findings contribute a molecular characterization of STING across hematological malignancies, facilitating the development of individualized prognosis and treatment strategies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1477100","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T07:36:05Z","timestamp":1738740965000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Bioinformatic characterization of STING expression in hematological malignancies reveals association with prognosis and anti-tumor immunity"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiang-mei","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-chun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-yuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-yu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-wei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08476","article-title":"STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity","volume":"461","author":"Ishikawa","year":"2009","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.7150\/thno.37574","article-title":"STING activation in cancer immunotherapy","volume":"9","author":"Su","year":"2019","journal-title":"Theranostics"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nature07317","article-title":"STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling","volume":"455","author":"Ishikawa","year":"2008","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00640-08","article-title":"MPYS, a novel membrane tetraspanner, is associated with major histocompatibility complex class II and mediates transduction of apoptotic signals","volume":"28","author":"Jin","year":"2008","journal-title":"Mol Cell Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI86892","article-title":"The host STING pathway at the interface of cancer and immunity","volume":"126","author":"Corrales","year":"2016","journal-title":"J Clin Invest"},{"key":"B6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ni.2491","article-title":"STING and the innate immune response to nucleic acids in the cytosol","volume":"14","author":"Burdette","year":"2013","journal-title":"Nat Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1922243117","article-title":"DNA-induced 2\u20193\u2019-cGAMP enhances haplotype-specific human STING cleavage by dengue protease","volume":"117","author":"Su","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/2159-8290.CD-19-0761","article-title":"The cytosolic DNA-sensing cGAS-STING pathway in cancer","volume":"10","author":"Kwon","year":"2020","journal-title":"Cancer Discovery"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1000-2","article-title":"Structural basis of STING binding with and phosphorylation by TBK1","volume":"567","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.14","article-title":"Antitumour actions of interferons: implications for cancer therapy","volume":"16","author":"Parker","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/cells11193028","article-title":"Dendritic cells: the long and evolving road towards successful targetability in cancer","volume":"11","author":"Marmonti","year":"2022","journal-title":"Cells"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.23.22.7947-7956.2003","article-title":"Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor alpha","volume":"23","author":"Luo","year":"2003","journal-title":"Mol Cell Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2009.03.022","article-title":"Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer","volume":"114","author":"de Jong","year":"2009","journal-title":"Gynecologic Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1038\/s41467-017-01566-5","article-title":"Host STING-dependent MDSC mobilization drives extrinsic radiation resistance","volume":"8","author":"Liang","year":"2017","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201846935","article-title":"Role of the cGAS-STING pathway in cancer development and oncotherapeutic approaches","volume":"19","author":"Khoo","year":"2018","journal-title":"EMBO Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/cas.v111.2","article-title":"Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer","volume":"111","author":"Loo","year":"2020","journal-title":"Cancer Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41467-017-00573-w","article-title":"Signalling strength determines proapoptotic functions of STING","volume":"8","author":"Gulen","year":"2017","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","first-page":"7978042","DOI":"10.1155\/2022\/7978042","article-title":"Identification of Cytosolic DNA Sensor cGAS-STING as Immune-Related Risk Factor in Renal Carcinoma following Pan-Cancer Analysis","volume":"2022","author":"Wu","year":"2022","journal-title":"J Immunol Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2018.11.003","article-title":"An analysis of the expression and association with immune cell infiltration of the cGAS\/STING pathway in pan-cancer","volume":"14","author":"An","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"B22","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","article-title":"Conserved pan-cancer microenvironment subtypes predict response to immunotherapy","volume":"39","author":"Bagaev","year":"2021","journal-title":"Cancer Cell"},{"key":"B23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40364-023-00460-1","article-title":"Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy","volume":"11","author":"Zhang","year":"2023","journal-title":"biomark Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5831247","DOI":"10.1155\/2022\/5831247","article-title":"Redox metabolism-associated molecular classification of clear cell renal cell carcinoma","volume":"2022","author":"Wei","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cellimm.2011.08.007","article-title":"Enhancement of HLA class II-restricted CD4+ T cell recognition of human melanoma cells following treatment with bryostatin-1","volume":"271","author":"Zhao","year":"2011","journal-title":"Cell Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"891","DOI":"10.14218\/JCTH.2021.00296","article-title":"Prognostic nomogram for hepatocellular carcinoma based on wound healing and immune checkpoint genes","volume":"10","author":"Hu","year":"2022","journal-title":"J Clin Transl Hepatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12957-022-02543-z","article-title":"An integrated analysis of prognostic and immune infiltrates for hub genes as potential survival indicators in patients with lung adenocarcinoma","volume":"20","author":"Xu","year":"2022","journal-title":"World J Surg Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41408-023-00819-5","article-title":"Which one is better for refractory\/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19\/CD22) CAR T-cell therapy","volume":"13","author":"Liu","year":"2023","journal-title":"Blood Cancer J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14102438","article-title":"Lymph nodes as anti-tumor immunotherapeutic tools: intranodal-tumor-specific antigen-pulsed dendritic cell vaccine immunotherapy","volume":"14","author":"Morisaki","year":"2022","journal-title":"Cancers"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102814","article-title":"Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy","volume":"12","author":"Wang","year":"2020","journal-title":"Aging"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nature20598","article-title":"A 17-gene stemness score for rapid determination of risk in acute leukaemia","volume":"540","author":"Ng","year":"2016","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12943-020-01250-1","article-title":"Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy","volume":"19","author":"Zheng","year":"2020","journal-title":"Mol Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.immuni.2021.04.019","article-title":"The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake","volume":"54","author":"de Mingo Pulido","year":"2021","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0387","article-title":"Metastasis and immune evasion from extracellular cGAMP hydrolysis","volume":"11","author":"Li","year":"2021","journal-title":"Cancer Discovery"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06464-z","article-title":"Non-cell-autonomous cancer progression from chromosomal instability","volume":"620","author":"Li","year":"2023","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","first-page":"10108","DOI":"10.3389\/ebm.2024.10108","article-title":"Prognostic implications of cGAS and STING gene expression in acute myeloid leukemia","volume":"249","author":"Chen","year":"2024","journal-title":"Exp Biol Med (Maywood)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306092","article-title":"Targeting the cGAS-STING pathway inhibits peripheral T-cell lymphoma progression and enhances the chemotherapeutic efficacy","volume":"11","author":"Lu","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-022-03065-6","article-title":"The stimulator of interferon genes (STING) agonists for treating acute myeloid leukemia (AML): current knowledge and future outlook","volume":"25","author":"Song","year":"2023","journal-title":"Clin Trans Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0998-5","article-title":"Cryo-EM structures of STING reveal its mechanism of activation by cyclic GMP-AMP","volume":"567","author":"Shang","year":"2019","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.05.023","article-title":"STING pathway activation stimulates potent immunity against acute myeloid leukemia","volume":"15","author":"Curran","year":"2016","journal-title":"Cell Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2123227119","article-title":"Activating STING1-dependent immune signaling in TP53 mutant and wild-type acute myeloid leukemia","volume":"119","author":"Kogan","year":"2022","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.v11.23","article-title":"SPP1 promotes radiation resistance through JAK2\/STAT3 pathway in esophageal carcinoma","volume":"11","author":"Wang","year":"2022","journal-title":"Cancer Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/nri3902","article-title":"Immunological hallmarks of stromal cells in the tumour microenvironment","volume":"15","author":"Turley","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"100905","DOI":"10.1016\/j.drup.2022.100905","article-title":"ABC transporters affects tumor immune microenvironment to regulate cancer immunotherapy and multidrug resistance","volume":"66","author":"Fan","year":"2023","journal-title":"Drug Resist Update"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.7150\/thno.73714","article-title":"Single-cell transcriptomics reveals the regulative roles of cancer associated fibroblasts in tumor immune microenvironment of recurrent osteosarcoma","volume":"12","author":"Huang","year":"2022","journal-title":"Theranostics"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2017.156","article-title":"Implications of the tumor immune microenvironment for staging and therapeutics","volume":"31","author":"Taube","year":"2018","journal-title":"Modern Pathol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13045-021-01103-4","article-title":"Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response","volume":"14","author":"Fu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41467-017-00101-w","article-title":"TRIM29 promotes DNA virus infections by inhibiting innate immune response","volume":"8","author":"Xing","year":"2017","journal-title":"Nat Commun"},{"key":"B49","doi-asserted-by":"publisher","first-page":"397","DOI":"10.4049\/jimmunol.1601999","article-title":"Cutting edge: activation of STING in T cells induces type I IFN responses and cell death","volume":"199","author":"Larkin","year":"2017","journal-title":"J Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.v10.9","article-title":"Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer","volume":"10","author":"Hu","year":"2021","journal-title":"Cancer Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13030","article-title":"Cytolytic activity (CYT) score is a prognostic biomarker reflecting host immune status in hepatocellular carcinoma (HCC)","volume":"38","author":"Wakiyama","year":"2018","journal-title":"Anticancer Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005741","article-title":"A clinical laboratory-developed LSC17 stemness score assay for rapid risk assessment of patients with acute myeloid leukemia","volume":"6","author":"Ng","year":"2022","journal-title":"Blood Adv"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1182\/blood-2021-150203","article-title":"Stemness signature predicts outcomes and identifies candidates for targeted therapy in diffuse large B-cell lymphoma","volume":"138","author":"Liang","year":"2021","journal-title":"Blood"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001185","article-title":"A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patients","volume":"4","author":"Wang","year":"2020","journal-title":"Blood Adv"},{"key":"B55","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13045-019-0721-x","article-title":"Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy","volume":"12","author":"Li","year":"2019","journal-title":"J Hematol Oncol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2019.10.010","article-title":"Homologous recombination repair deficiency and the immune response in breast cancer: A literature review","volume":"13","author":"Pellegrino","year":"2020","journal-title":"Trans Oncol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.08.019","article-title":"Immunogenomic landscape of hematological Malignancies","volume":"38","author":"Dufva","year":"2020","journal-title":"Cancer Cell"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1683347","DOI":"10.1080\/2162402X.2019.1683347","article-title":"The M2 macrophage marker CD206: a novel prognostic indicator for acute myeloid leukemia","volume":"9","author":"Xu","year":"2020","journal-title":"Oncoimmunology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/cam4.v12.1","article-title":"Pan-cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia","volume":"12","author":"Xu","year":"2023","journal-title":"Cancer Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","article-title":"Machine learning identifies stemness features associated with oncogenic dedifferentiation","volume":"173","author":"Malta","year":"2018","journal-title":"Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1477100\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T07:36:11Z","timestamp":1738740971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1477100\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":62,"alternative-id":["10.3389\/fimmu.2025.1477100"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1477100","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"article-number":"1477100"}}